AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Targeted Medical Pharma, Inc.

$0 -$0.00 (-90.00%)
OTC · 14 Sep 2026 20:00 UTC
Previous Close
$0
Day Range
$0$0
Year Range
$0$0.02
Market Cap
302
AVG Volume
46
Trailing/Forward PE
-0/-
PEG ratio
-0
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Revenue (USD)
01M2M3M13 Q313 Q414 Q114 Q214 Q314 Q415 Q115 Q215 Q315 Q4
TRGM Revenue (USD) by quarter
PeriodRevenue (USD)
15 Q41.29M
15 Q31.56M
15 Q21.34M
15 Q11.07M
14 Q41.42M
14 Q31.67M
14 Q22.22M
14 Q11.8M
13 Q42.63M
13 Q32.19M
Net Income (USD)
-2M-1M01M13 Q313 Q414 Q114 Q214 Q314 Q415 Q115 Q215 Q315 Q4
TRGM Net Income (USD) by quarter
PeriodNet Income (USD)
15 Q4-581.47K
15 Q3-237.76K
15 Q2-546.17K
15 Q1-1.68M
14 Q4-1.48M
14 Q3-1.01M
14 Q2-423.22K
14 Q1-974.47K
13 Q4497.29K
13 Q3-1.72M
Operating Income (USD)
-2M-1.5M-1M-500K013 Q313 Q414 Q114 Q214 Q314 Q415 Q115 Q215 Q315 Q4
TRGM Operating Income (USD) by quarter
PeriodOperating Income (USD)
15 Q4-366.96K
15 Q3-16.97K
15 Q2-371.07K
15 Q1-1.27M
14 Q4-1.12M
14 Q3-687.82K
14 Q2-96.04K
14 Q1-710.79K
13 Q4-10K
13 Q3-1.5M
EBITDA (USD)
-1.5M-1M-500K0500K13 Q313 Q414 Q114 Q214 Q314 Q415 Q115 Q215 Q315 Q4
TRGM EBITDA (USD) by quarter
PeriodEBITDA (USD)
15 Q4-313.31K
15 Q379.19K
15 Q2-221.81K
15 Q1-1.21M
14 Q4-1.02M
14 Q3-626.3K
14 Q26.76K
14 Q1-605.79K
13 Q4119.26K
13 Q3-1.4M
Cash Flows (USD)
-2M-1M01M13 Q313 Q414 Q114 Q214 Q314 Q415 Q115 Q215 Q315 Q4
TRGM Cash Flows (USD) by quarter
PeriodCash Flows (USD)
15 Q476.54K
15 Q3132.23K
15 Q2-21.94K
15 Q1-1.47M
14 Q4237.71K
14 Q3188.47K
14 Q2431.07K
14 Q1-76.94K
13 Q4-1.86M
13 Q3109.63K
EPS (USD)
-0.08-0.05-0.03-00.0213 Q313 Q414 Q114 Q214 Q314 Q415 Q115 Q215 Q315 Q4
TRGM EPS (USD) by quarter
PeriodEPS (USD)
15 Q4-0.02
15 Q3-0.01
15 Q2-0.02
15 Q1-0.06
14 Q4-0.06
14 Q3-0.04
14 Q2-0.02
14 Q1-0.04
13 Q40.02
13 Q3-0.07
Expenses (USD)
-1M01M2M3M4MR&DSG&ACapex13 Q313 Q414 Q114 Q214 Q314 Q415 Q115 Q215 Q315 Q4
TRGM Expenses (USD) by quarter
PeriodExpenses (USD)
15 Q41.23M
15 Q31.06M
15 Q21.18M
15 Q11.8M
14 Q41.88M
14 Q31.82M
14 Q21.81M
14 Q11.95M
13 Q41.91M
13 Q33.08M
Cash & Debt (USD)
02M4M6MCashLong Term DebtShort Term Debt13 Q313 Q414 Q114 Q214 Q314 Q415 Q115 Q215 Q315 Q4
TRGM Cash & Debt (USD) by quarter
PeriodCash & Debt (USD)
15 Q482.64K
15 Q320.61K
15 Q221.37K
15 Q1223.19K
14 Q411.74K
14 Q340.52K
14 Q225.14K
14 Q192.59K
13 Q4491.81K
13 Q3167.87K
Debt ratios
-4-3-2-1013 Q313 Q414 Q114 Q214 Q314 Q415 Q115 Q215 Q315 Q4
TRGM Debt ratios by quarter
PeriodDebt ratios
15 Q4-3.13
15 Q3-2.2
15 Q2-1.71
15 Q1-1.8
14 Q4-1.65
14 Q3-3.5
14 Q2-2.12
14 Q1-1.19
13 Q4-1.28
13 Q3-0.8
Margins
0%20%40%60%80%13 Q313 Q414 Q114 Q214 Q314 Q415 Q115 Q215 Q315 Q4
TRGM Margins by quarter
PeriodMargins
15 Q460.2%
15 Q368.16%
15 Q260.16%
15 Q148.42%
14 Q454.02%
14 Q370.38%
14 Q277.04%
14 Q168.93%
13 Q472.57%
13 Q371.15%
Return on Capital
-10%0%10%20%13 Q313 Q414 Q114 Q214 Q314 Q415 Q115 Q215 Q315 Q4
TRGM Return on Capital by quarter
PeriodReturn on Capital
15 Q44.5%
15 Q31.93%
15 Q24.51%
15 Q114.44%
14 Q414.88%
14 Q311.64%
14 Q25.33%
14 Q112.95%
13 Q4-7.09%
13 Q318.95%
Shares Outstanding
010M20M30M13 Q313 Q414 Q114 Q214 Q314 Q415 Q115 Q215 Q315 Q4
TRGM Shares Outstanding by quarter
PeriodShares Outstanding
15 Q427.22M
15 Q327.46M
15 Q226.95M
15 Q126.77M
14 Q426.58M
14 Q326.54M
14 Q226.42M
14 Q125.9M
13 Q424.87M
13 Q323.95M
Book Value Per Share (USD)
-0.6-0.4-0.2-013 Q313 Q414 Q114 Q214 Q314 Q415 Q115 Q215 Q315 Q4
TRGM Book Value Per Share (USD) by quarter
PeriodBook Value Per Share (USD)
15 Q4-0.47
15 Q3-0.45
15 Q2-0.45
15 Q1-0.43
14 Q4-0.38
14 Q3-0.33
14 Q2-0.3
14 Q1-0.29
13 Q4-0.28
13 Q3-0.38
Total Assets (USD)
02M4M6M13 Q313 Q414 Q114 Q214 Q314 Q415 Q115 Q215 Q315 Q4
TRGM Total Assets (USD) by quarter
PeriodTotal Assets (USD)
15 Q42.43M
15 Q32.45M
15 Q22.4M
15 Q12.8M
14 Q42.5M
14 Q33.22M
14 Q23.82M
14 Q14.58M
13 Q45M
13 Q34.93M
Free Cash Flow Yield
-600000%-400000%-200000%0%med -46976.81%Jan 25May 25Sep 25Jan 26May 26Sep 26
TRGM Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-469768.06%
Sep 26-469768.06%
Sep 26-469768.06%
Aug 26-469768.06%
Aug 26-469768.06%
Aug 26-469768.06%
Aug 26-469768.06%
Jul 26-469768.06%
Jul 26-469768.06%
Jul 26-469768.06%
Jul 26-469768.06%
Jul 26-469768.06%
Jun 26-469768.06%
Jun 26-469768.06%
Jun 26-469768.06%
Jun 26-469768.06%
May 26-469768.06%
May 26-469768.06%
May 26-469768.06%
May 26-46976.81%
May 26-46976.81%
Apr 26-46976.81%
Apr 26-46976.81%
Apr 26-46976.81%
Apr 26-46976.81%
Mar 26-46976.81%
Mar 26-46976.81%
Mar 26-46976.81%
Mar 26-46976.81%
Feb 26-46976.81%
Feb 26-46976.81%
Feb 26-46976.81%
Feb 26-46976.81%
Jan 26-46976.81%
Jan 26-46976.81%
Jan 26-46976.81%
Jan 26-46976.81%
Jan 26-46976.81%
Dec 25-46976.81%
Dec 25-46976.81%
Dec 25-46976.81%
Dec 25-46976.81%
Nov 25-46976.81%
Nov 25-46976.81%
Nov 25-46976.81%
Nov 25-46976.81%
Oct 25-46976.81%
Oct 25-46976.81%
Oct 25-46976.81%
Oct 25-46976.81%
Oct 25-46976.81%
Sep 25-46976.81%
Sep 25-46976.81%
Sep 25-46976.81%
Sep 25-46976.81%
Aug 25-46976.81%
Aug 25-46976.81%
Aug 25-46976.81%
Aug 25-46976.81%
Aug 25-46976.81%
Jul 25-46976.81%
Jul 25-46976.81%
Jul 25-46976.81%
Jul 25-46976.81%
Jun 25-46976.81%
Jun 25-46976.81%
Jun 25-46976.81%
Jun 25-46976.81%
May 25-46976.81%
May 25-46976.81%
May 25-46976.81%
May 25-46976.81%
May 25-46976.81%
Apr 25-46976.81%
Apr 25-46976.81%
Apr 25-46976.81%
Apr 25-46976.81%
Mar 25-46976.81%
Mar 25-46976.81%
Mar 25-46976.81%
Mar 25-46976.81%
Feb 25-46976.81%
Feb 25-46976.81%
Feb 25-46976.81%
Feb 25-46976.81%
Jan 25-46976.81%
Jan 25-46976.81%
Jan 25-46976.81%
Jan 25-46976.81%
Jan 25-46976.81%
Dec 24-46976.81%
Dec 24-46976.81%
Dec 24-46976.81%
Dec 24-46976.81%
Nov 24-46976.81%
Nov 24-46976.81%
Nov 24-46976.81%
May 23-46976.81%
May 23-46976.81%
May 23-46976.81%
Price to Sales
0000med 0Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
TRGM Price to Sales by quarter
PeriodPrice to Sales
Sep 260
Sep 260
Sep 260
Aug 260
Aug 260
Aug 260
Aug 260
Jul 260
Jul 260
Jul 260
Jul 260
Jul 260
Jun 260
Jun 260
Jun 260
Jun 260
May 260
May 260
May 260
May 260
May 260
Apr 260
Apr 260
Apr 260
Apr 260
Mar 260
Mar 260
Mar 260
Mar 260
Feb 260
Feb 260
Feb 260
Feb 260
Jan 260
Jan 260
Jan 260
Jan 260
Jan 260
Dec 250
Dec 250
Dec 250
Dec 250
Nov 250
Nov 250
Nov 250
Nov 250
Oct 250
Oct 250
Oct 250
Oct 250
Oct 250
Sep 250
Sep 250
Sep 250
Sep 250
Aug 250
Aug 250
Aug 250
Aug 250
Aug 250
Jul 250
Jul 250
Jul 250
Jul 250
Jun 250
Jun 250
Jun 250
Jun 250
May 250
May 250
May 250
May 250
May 250
Apr 250
Apr 250
Apr 250
Apr 250
Mar 250
Mar 250
Mar 250
Mar 250
Feb 250
Feb 250
Feb 250
Feb 250
Jan 250
Jan 250
Jan 250
Jan 250
Jan 250
Dec 240
Dec 240
Dec 240
Dec 240
Nov 240
Nov 240
Nov 240
May 230
May 230
May 230
Price/Operating Cashflow
0200400600med 203.24Oct 13Nov 13Jan 14Feb 14Apr 15May 15Jun 15
TRGM Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Jun 154
Jun 153.92
Jun 155.11
Jun 155.11
May 153.41
May 153.07
May 152.32
May 153.75
May 156.81
Apr 155.11
Apr 153.41
Apr 156.81
Apr 154.09
Mar 14369.68
Mar 14347.68
Mar 14330.07
Mar 14352.08
Feb 14303.67
Feb 14382.88
Feb 14404.89
Feb 14365.28
Jan 14352.08
Jan 14338.87
Jan 14281.62
Jan 14355.16
Jan 14382.88
Dec 13202.26
Dec 13190.97
Dec 13151.82
Dec 13232.63
Nov 13266.91
Nov 13249.77
Nov 13193.45
Nov 13208.14
Nov 13227.73
Oct 13119.99
Oct 13203.24
Oct 13183.65
Oct 13230.18
Targeted Medical Pharma, Inc.
TRGM
Stockpicker

Video analysis: TRGM

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.